
Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice
Keywords: Naringenin; Diabetes; Cardiac hypertrophy; PPARs; EETs; CYP2J3; AA; arachidonic acid; ANF; atrial natriuretic factor; BW; body weight; CVF; collagen volume fraction; CYP450; cytochrome P450; DCM; diabetic cardiomyopathy; DHM; diabetic cardiac hypertrophy